Gene · 2303
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WNT5A, β‑catenin and SUFU expression patterns, and the significance of microRNA deregulation in placentas with intrauterine growth restriction. | Mol Med Rep | 2023 | 36524356 | PubTator, text mining | PubMed |
| SUMOylation of TUFT1 is essential for gastric cancer progression through AKT/mTOR signaling pathway activation. | Cancer Sci | 2023 | 36380570 | PubTator, text mining | PubMed |
| Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis. | Noncoding RNA Res | 2023 | 36311994 | PubTator, text mining | PubMed |
| Targeting Transcription Factors in Cancer: From "Undruggable" to "Druggable". | Methods Mol Biol | 2023 | 36264492 | PubTator, text mining | PubMed |
| The effect of a-Lipoic acid (ALA) on oxidative stress, inflammation, and apoptosis in high glucose-induced human corneal epithelial cells. | Graefes Arch Clin Exp Ophthalmol | 2023 | 36058948 | PubTator, text mining | PubMed |
| Homology modeling of Forkhead box protein C2: identification of potential inhibitors using ligand and structure-based virtual screening. | Mol Divers | 2023 | 36048303 | PubTator, text mining | PubMed |
| SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance. | Cancer Med | 2023 | 35676831 | PubTator, text mining | PubMed |
| Podocyte-specific Transcription Factors: Could MafB Become a Therapeutic Target for Kidney Disease? | Intern Med | 2023 | 35249929 | PubTator, text mining | PubMed |
| Redefining WILD syndrome: a primary lymphatic dysplasia with congenital multisegmental lymphoedema, cutaneous lymphovascular malformation, CD4 lymphopaenia and warts. | J Med Genet | 2023 | 34916230 | PubTator, text mining | PubMed |
| Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective. | Oncol Res | 2022 | 37305018 | PubTator, text mining | PubMed |
| circRNAs in drug resistance of breast cancer. | Oncol Res | 2022 | 37304411 | PubTator, text mining | PubMed |
| Idiopathic thoracolumbar spinal epidural arachnoid cysts: A case report and systematic review. | Surg Neurol Int | 2022 | 36761263 | PubTator, text mining | PubMed |
| Pharmacological inhibition of FOXO1 promotes lymphatic valve growth in a congenital lymphedema mouse model. | Front Cell Dev Biol | 2022 | 36742198 | PubTator, text mining | PubMed |
| DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1. | Cancer Res Commun | 2022 | 36713812 | PubTator, text mining | PubMed |
| Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models. | Front Oncol | 2022 | 36686779 | PubTator, text mining | PubMed |
| Noncoding RNAs in Vascular Cell Biology and Restenosis. | Biology (Basel) | 2022 | 36671717 | PubTator, text mining | PubMed |
| Updated Perspectives on Direct Vascular Cellular Reprogramming and Their Potential Applications in Tissue Engineered Vascular Grafts. | J Funct Biomater | 2022 | 36662068 | PubTator, text mining | PubMed |
| The clinical and genetic findings in a Chinese family with Axenfeld-Rieger syndrome. | Heliyon | 2022 | 36619412 | PubTator, text mining | PubMed |
| Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling. | Int J Mol Sci | 2022 | 36613607 | PubTator, text mining | PubMed |
| A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation. | Medicine (Baltimore) | 2022 | 36595859 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2303/papers?page=18